Amgen, Takeda Acquisition Targets Involve Limited Exposure To Medicare – And Price Controls

Prospect of Medicare price setting under the Inflation Reduction Act was factored into the rationale for two recent and notable deals for products with limited exposure to the government insurance program.

M&A perspectives
Recent M&A deals suggest industry is appreciating the impact of IRA, the new Medicare pricing law. • Source: Shutterstock

More from Market Access

More from Pink Sheet